Walking out of the CLAT 2026 examination centre, confidence wasn’t her immediate reaction. Like many candidates around her, ...
Using the Australian SKA Pathfinder (ASKAP) telescope, astronomers have discovered a new millisecond pulsar (MSPs) at a ...
The much-awaited K-drama Study Group started airing on January 23, 2025, on TVING in South Korea. It followed a ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with ...
India Today on MSN
CLAT 2026 AIR 1 Geetali Gupta says chasing ranks was never her strategy
At just 17, Geetali Gupta's CLAT 2026 triumph is as much about mental balance as it is about academic excellence. The AIR 1 ...
Insider.comNews Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faster regulatory pathways that could accelerate oncology ...
Naval Postgraduate School (NPS) students U.S. Navy Lt. Cmdr. Max Leutermann and Swedish Armed Forces Maj. Patrik Liljegard, ...
Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...
Some patients dropped out of the trial early because they had lost so much weight.
Financing includes participation from leading institutional investors including Janus Henderson Investors, Brahma Capital, Biotrack Capital, Cormorant Asset Management, OrbiMed, Plaisance Capital ...
Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback